GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (HKSE:06160) » Definitions » E10

BeiGene (HKSE:06160) E10 : HK$-7.25 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BeiGene E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BeiGene's adjusted earnings per share data for the three months ended in Mar. 2024 was HK$-1.486. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$-7.25 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-09), BeiGene's current stock price is HK$95.35. BeiGene's E10 for the quarter that ended in Mar. 2024 was HK$-7.25. BeiGene's Shiller PE Ratio of today is .


BeiGene E10 Historical Data

The historical data trend for BeiGene's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeiGene E10 Chart

BeiGene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -7.18

BeiGene Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -7.18 -7.25

Competitive Comparison of BeiGene's E10

For the Biotechnology subindustry, BeiGene's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeiGene's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeiGene's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BeiGene's Shiller PE Ratio falls into.



BeiGene E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BeiGene's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.486/131.7762*131.7762
=-1.486

Current CPI (Mar. 2024) = 131.7762.

BeiGene Quarterly Data

per share eps CPI Adj_EPS
201406 0.000 100.560 0.000
201409 -0.108 100.428 -0.142
201412 -0.042 99.070 -0.056
201503 -0.113 99.621 -0.149
201506 -0.063 100.684 -0.082
201509 -0.155 100.392 -0.203
201512 -0.515 99.792 -0.680
201603 -0.543 100.470 -0.712
201606 -0.466 101.688 -0.604
201609 -0.621 101.861 -0.803
201612 -0.566 101.863 -0.732
201703 -0.777 102.862 -0.995
201706 -0.936 103.349 -1.193
201709 1.563 104.136 1.978
201712 -1.311 104.011 -1.661
201803 -1.255 105.290 -1.571
201806 -1.726 106.317 -2.139
201809 -1.489 106.507 -1.842
201812 -2.737 105.998 -3.403
201903 -1.727 107.251 -2.122
201906 -0.861 108.070 -1.050
201909 -3.056 108.329 -3.717
201912 -3.824 108.420 -4.648
202003 -2.809 108.902 -3.399
202006 -2.558 108.767 -3.099
202009 -2.868 109.815 -3.442
202012 -3.101 109.897 -3.718
202103 0.388 111.754 0.458
202106 -3.122 114.631 -3.589
202109 -2.827 115.734 -3.219
202112 -3.666 117.630 -4.107
202203 -2.582 121.301 -2.805
202206 -3.296 125.017 -3.474
202209 -3.218 125.227 -3.386
202212 -2.569 125.222 -2.703
202303 -2.041 127.348 -2.112
202306 -2.193 128.729 -2.245
202309 1.174 129.860 1.191
202312 -2.109 129.419 -2.147
202403 -1.486 131.776 -1.486

Add all the adjusted EPS together and divide 10 will get our e10.


BeiGene  (HKSE:06160) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BeiGene E10 Related Terms

Thank you for viewing the detailed overview of BeiGene's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BeiGene (HKSE:06160) Business Description

Traded in Other Exchanges
Address
c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108
BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.
Executives
Jpmorgan Chase & Co. 2502 Approved lending agent
Oyler John Victor 2101 Beneficial owner
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Baker Felix James 2201 Interest of corporation controlled by you
Baker Julian Charles 2201 Interest of corporation controlled by you
Baker Bros. Advisors (gp) Llc 2201 Interest of corporation controlled by you
Baker Brothers Life Sciences Capital, L.p. 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Amgen Inc. 2101 Beneficial owner
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner
Fidelity Management & Research Company
Fmr Co., Inc.

BeiGene (HKSE:06160) Headlines

No Headlines